Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23


Watch the webcasts from our industry partners Satellite Symposia

Treatment Considerations for Advanced NSCLC: Now and in the Future 

Boehringer Ingelheim

The role of immuno-oncology in the evolving treatment landscapes of upper GI cancers

Bristol Myers Squibb

Expanding the horizon for the treatment of solid tumors with antibody drug conjugates (ADCs)

Daiichi Sankyo

Beyond 2020: Targeting EGFR Exon 19 and Exon 21 L858R in the New Era


Clinical Evidence to Real-World Experience: Bridging the Best of Both Worlds in the Management of ER+ HER2- mBC


Leveraging Novel Antibody-Drug Conjugates in a World of Evolving Treatment Paradigms: A Pan-Tumour Perspective

Physicians' Education Resource

Optimization of treatment strategy in advanced pancreatic cancer for Asian patients


This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.